nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—multiple sclerosis	0.382	1	CbGaD
Mefloquine—CYP19A1—Betamethasone—multiple sclerosis	0.0654	0.173	CbGbCtD
Mefloquine—BCHE—Triamcinolone—multiple sclerosis	0.0635	0.168	CbGbCtD
Mefloquine—CYP19A1—Dexamethasone—multiple sclerosis	0.038	0.101	CbGbCtD
Mefloquine—CYP2D6—Fingolimod—multiple sclerosis	0.0311	0.0823	CbGbCtD
Mefloquine—ABCB1—Methylprednisolone—multiple sclerosis	0.0213	0.0563	CbGbCtD
Mefloquine—CYP3A4—Fingolimod—multiple sclerosis	0.0198	0.0523	CbGbCtD
Mefloquine—ABCB1—Mitoxantrone—multiple sclerosis	0.0155	0.0411	CbGbCtD
Mefloquine—ABCB1—Betamethasone—multiple sclerosis	0.0138	0.0366	CbGbCtD
Mefloquine—ABCB1—Prednisolone—multiple sclerosis	0.0136	0.0361	CbGbCtD
Mefloquine—ABCB1—Prednisone—multiple sclerosis	0.0129	0.0341	CbGbCtD
Mefloquine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0127	0.0337	CbGbCtD
Mefloquine—HBA2—leg—multiple sclerosis	0.0121	0.218	CbGeAlD
Mefloquine—CYP3A4—Triamcinolone—multiple sclerosis	0.00965	0.0256	CbGbCtD
Mefloquine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00929	0.0246	CbGbCtD
Mefloquine—CYP3A4—Betamethasone—multiple sclerosis	0.00828	0.0219	CbGbCtD
Mefloquine—CYP3A4—Prednisolone—multiple sclerosis	0.00817	0.0216	CbGbCtD
Mefloquine—ABCB1—Dexamethasone—multiple sclerosis	0.00804	0.0213	CbGbCtD
Mefloquine—CYP3A4—Prednisone—multiple sclerosis	0.00772	0.0204	CbGbCtD
Mefloquine—CYP2D6—Dexamethasone—multiple sclerosis	0.00758	0.0201	CbGbCtD
Mefloquine—ABCB1—Methotrexate—multiple sclerosis	0.00646	0.0171	CbGbCtD
Mefloquine—CYP3A4—Dexamethasone—multiple sclerosis	0.00482	0.0128	CbGbCtD
Mefloquine—HBA1—brainstem—multiple sclerosis	0.00306	0.0555	CbGeAlD
Mefloquine—ADORA1—nerve—multiple sclerosis	0.00294	0.0533	CbGeAlD
Mefloquine—HBA2—retina—multiple sclerosis	0.00271	0.0491	CbGeAlD
Mefloquine—HBA1—spinal cord—multiple sclerosis	0.0019	0.0345	CbGeAlD
Mefloquine—HBA2—spinal cord—multiple sclerosis	0.00175	0.0317	CbGeAlD
Mefloquine—HBA1—nervous system—multiple sclerosis	0.0016	0.0291	CbGeAlD
Mefloquine—HBA1—central nervous system—multiple sclerosis	0.00154	0.028	CbGeAlD
Mefloquine—HBA1—cerebellum—multiple sclerosis	0.00151	0.0274	CbGeAlD
Mefloquine—HBA2—nervous system—multiple sclerosis	0.00147	0.0267	CbGeAlD
Mefloquine—HBA2—central nervous system—multiple sclerosis	0.00142	0.0257	CbGeAlD
Mefloquine—HBA2—cerebellum—multiple sclerosis	0.00139	0.0251	CbGeAlD
Mefloquine—HBA1—brain—multiple sclerosis	0.00123	0.0222	CbGeAlD
Mefloquine—HBA2—brain—multiple sclerosis	0.00112	0.0204	CbGeAlD
Mefloquine—ADORA2A—spinal cord—multiple sclerosis	0.000909	0.0165	CbGeAlD
Mefloquine—ADORA1—medulla oblongata—multiple sclerosis	0.00088	0.016	CbGeAlD
Mefloquine—ACHE—medulla oblongata—multiple sclerosis	0.000875	0.0159	CbGeAlD
Mefloquine—ADORA1—midbrain—multiple sclerosis	0.000805	0.0146	CbGeAlD
Mefloquine—ACHE—midbrain—multiple sclerosis	0.0008	0.0145	CbGeAlD
Mefloquine—ADORA1—spinal cord—multiple sclerosis	0.000785	0.0142	CbGeAlD
Mefloquine—ACHE—spinal cord—multiple sclerosis	0.00078	0.0141	CbGeAlD
Mefloquine—ADORA2A—nervous system—multiple sclerosis	0.000766	0.0139	CbGeAlD
Mefloquine—ADORA2A—central nervous system—multiple sclerosis	0.000738	0.0134	CbGeAlD
Mefloquine—ADORA2A—cerebellum—multiple sclerosis	0.000721	0.0131	CbGeAlD
Mefloquine—ADORA1—nervous system—multiple sclerosis	0.000661	0.012	CbGeAlD
Mefloquine—ADORA1—central nervous system—multiple sclerosis	0.000637	0.0115	CbGeAlD
Mefloquine—ADORA1—cerebellum—multiple sclerosis	0.000622	0.0113	CbGeAlD
Mefloquine—ACHE—cerebellum—multiple sclerosis	0.000619	0.0112	CbGeAlD
Mefloquine—BCHE—brainstem—multiple sclerosis	0.000617	0.0112	CbGeAlD
Mefloquine—ADORA2A—brain—multiple sclerosis	0.000586	0.0106	CbGeAlD
Mefloquine—ADORA1—brain—multiple sclerosis	0.000506	0.00917	CbGeAlD
Mefloquine—ACHE—brain—multiple sclerosis	0.000502	0.00911	CbGeAlD
Mefloquine—CYP19A1—nervous system—multiple sclerosis	0.000449	0.00813	CbGeAlD
Mefloquine—CYP19A1—central nervous system—multiple sclerosis	0.000432	0.00783	CbGeAlD
Mefloquine—BCHE—medulla oblongata—multiple sclerosis	0.00043	0.0078	CbGeAlD
Mefloquine—CYP2D6—brainstem—multiple sclerosis	0.000409	0.00741	CbGeAlD
Mefloquine—BCHE—midbrain—multiple sclerosis	0.000393	0.00713	CbGeAlD
Mefloquine—BCHE—spinal cord—multiple sclerosis	0.000383	0.00695	CbGeAlD
Mefloquine—CYP19A1—brain—multiple sclerosis	0.000343	0.00622	CbGeAlD
Mefloquine—BCHE—nervous system—multiple sclerosis	0.000323	0.00586	CbGeAlD
Mefloquine—BCHE—central nervous system—multiple sclerosis	0.000311	0.00564	CbGeAlD
Mefloquine—BCHE—cerebellum—multiple sclerosis	0.000304	0.00551	CbGeAlD
Mefloquine—ABCB1—retina—multiple sclerosis	0.000284	0.00514	CbGeAlD
Mefloquine—BCHE—brain—multiple sclerosis	0.000247	0.00448	CbGeAlD
Mefloquine—CYP3A4—nervous system—multiple sclerosis	0.000218	0.00394	CbGeAlD
Mefloquine—CYP2D6—nervous system—multiple sclerosis	0.000214	0.00388	CbGeAlD
Mefloquine—CYP3A4—central nervous system—multiple sclerosis	0.000209	0.0038	CbGeAlD
Mefloquine—CYP2D6—central nervous system—multiple sclerosis	0.000206	0.00374	CbGeAlD
Mefloquine—ABCB1—medulla oblongata—multiple sclerosis	0.000205	0.00372	CbGeAlD
Mefloquine—CYP2D6—cerebellum—multiple sclerosis	0.000201	0.00365	CbGeAlD
Mefloquine—ABCB1—midbrain—multiple sclerosis	0.000187	0.0034	CbGeAlD
Mefloquine—ABCB1—spinal cord—multiple sclerosis	0.000183	0.00331	CbGeAlD
Mefloquine—CYP2D6—brain—multiple sclerosis	0.000164	0.00297	CbGeAlD
Mefloquine—ABCB1—nervous system—multiple sclerosis	0.000154	0.00279	CbGeAlD
Mefloquine—ABCB1—central nervous system—multiple sclerosis	0.000148	0.00269	CbGeAlD
Mefloquine—ABCB1—cerebellum—multiple sclerosis	0.000145	0.00263	CbGeAlD
Mefloquine—Renal failure—Methotrexate—multiple sclerosis	0.000121	0.00103	CcSEcCtD
Mefloquine—Angiopathy—Prednisone—multiple sclerosis	0.00012	0.00102	CcSEcCtD
Mefloquine—Confusional state—Methylprednisolone—multiple sclerosis	0.000119	0.00102	CcSEcCtD
Mefloquine—Malaise—Betamethasone—multiple sclerosis	0.000119	0.00101	CcSEcCtD
Mefloquine—Malaise—Dexamethasone—multiple sclerosis	0.000119	0.00101	CcSEcCtD
Mefloquine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Oedema—Triamcinolone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Vertigo—Dexamethasone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Vertigo—Betamethasone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Syncope—Betamethasone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—Syncope—Dexamethasone—multiple sclerosis	0.000118	0.00101	CcSEcCtD
Mefloquine—ABCB1—brain—multiple sclerosis	0.000118	0.00213	CbGeAlD
Mefloquine—Sweating—Methotrexate—multiple sclerosis	0.000118	0.001	CcSEcCtD
Mefloquine—Shock—Triamcinolone—multiple sclerosis	0.000117	0.000995	CcSEcCtD
Mefloquine—Insomnia—Prednisolone—multiple sclerosis	0.000117	0.000994	CcSEcCtD
Mefloquine—Alopecia—Prednisone—multiple sclerosis	0.000116	0.000994	CcSEcCtD
Mefloquine—Shock—Methylprednisolone—multiple sclerosis	0.000116	0.000992	CcSEcCtD
Mefloquine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000116	0.00099	CcSEcCtD
Mefloquine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000116	0.000989	CcSEcCtD
Mefloquine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000116	0.000988	CcSEcCtD
Mefloquine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000116	0.000988	CcSEcCtD
Mefloquine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000116	0.000987	CcSEcCtD
Mefloquine—Paraesthesia—Prednisolone—multiple sclerosis	0.000116	0.000987	CcSEcCtD
Mefloquine—Tachycardia—Triamcinolone—multiple sclerosis	0.000116	0.000987	CcSEcCtD
Mefloquine—Mental disorder—Prednisone—multiple sclerosis	0.000115	0.000985	CcSEcCtD
Mefloquine—Nausea—Azathioprine—multiple sclerosis	0.000115	0.000985	CcSEcCtD
Mefloquine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000115	0.000984	CcSEcCtD
Mefloquine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000115	0.00098	CcSEcCtD
Mefloquine—Erythema—Prednisone—multiple sclerosis	0.000115	0.000979	CcSEcCtD
Mefloquine—Malnutrition—Prednisone—multiple sclerosis	0.000115	0.000979	CcSEcCtD
Mefloquine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000115	0.000977	CcSEcCtD
Mefloquine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000114	0.000977	CcSEcCtD
Mefloquine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000114	0.000975	CcSEcCtD
Mefloquine—Convulsion—Betamethasone—multiple sclerosis	0.000114	0.000974	CcSEcCtD
Mefloquine—Convulsion—Dexamethasone—multiple sclerosis	0.000114	0.000974	CcSEcCtD
Mefloquine—Hypertension—Betamethasone—multiple sclerosis	0.000114	0.00097	CcSEcCtD
Mefloquine—Hypertension—Dexamethasone—multiple sclerosis	0.000114	0.00097	CcSEcCtD
Mefloquine—Asthenia—Mitoxantrone—multiple sclerosis	0.000113	0.000961	CcSEcCtD
Mefloquine—Myalgia—Betamethasone—multiple sclerosis	0.000112	0.000957	CcSEcCtD
Mefloquine—Myalgia—Dexamethasone—multiple sclerosis	0.000112	0.000957	CcSEcCtD
Mefloquine—Anxiety—Betamethasone—multiple sclerosis	0.000112	0.000954	CcSEcCtD
Mefloquine—Anxiety—Dexamethasone—multiple sclerosis	0.000112	0.000954	CcSEcCtD
Mefloquine—Discomfort—Dexamethasone—multiple sclerosis	0.000111	0.000945	CcSEcCtD
Mefloquine—Discomfort—Betamethasone—multiple sclerosis	0.000111	0.000945	CcSEcCtD
Mefloquine—Hypotension—Methylprednisolone—multiple sclerosis	0.00011	0.000943	CcSEcCtD
Mefloquine—Vision blurred—Prednisone—multiple sclerosis	0.000108	0.000922	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000108	0.000921	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000108	0.000919	CcSEcCtD
Mefloquine—Oedema—Betamethasone—multiple sclerosis	0.000108	0.000917	CcSEcCtD
Mefloquine—Oedema—Dexamethasone—multiple sclerosis	0.000108	0.000917	CcSEcCtD
Mefloquine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000108	0.000917	CcSEcCtD
Mefloquine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000108	0.000917	CcSEcCtD
Mefloquine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000107	0.000917	CcSEcCtD
Mefloquine—Insomnia—Triamcinolone—multiple sclerosis	0.000107	0.000914	CcSEcCtD
Mefloquine—Insomnia—Methylprednisolone—multiple sclerosis	0.000107	0.000912	CcSEcCtD
Mefloquine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000106	0.000908	CcSEcCtD
Mefloquine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000106	0.000908	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000106	0.000906	CcSEcCtD
Mefloquine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000106	0.000906	CcSEcCtD
Mefloquine—Visual impairment—Methotrexate—multiple sclerosis	0.000106	0.000906	CcSEcCtD
Mefloquine—Shock—Betamethasone—multiple sclerosis	0.000106	0.000902	CcSEcCtD
Mefloquine—Shock—Dexamethasone—multiple sclerosis	0.000106	0.000902	CcSEcCtD
Mefloquine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000106	0.000901	CcSEcCtD
Mefloquine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000105	0.0009	CcSEcCtD
Mefloquine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000105	0.0009	CcSEcCtD
Mefloquine—Agitation—Prednisone—multiple sclerosis	0.000105	0.000899	CcSEcCtD
Mefloquine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000105	0.000898	CcSEcCtD
Mefloquine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000105	0.000898	CcSEcCtD
Mefloquine—Tachycardia—Betamethasone—multiple sclerosis	0.000105	0.000895	CcSEcCtD
Mefloquine—Tachycardia—Dexamethasone—multiple sclerosis	0.000105	0.000895	CcSEcCtD
Mefloquine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000104	0.00089	CcSEcCtD
Mefloquine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000104	0.000888	CcSEcCtD
Mefloquine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000104	0.000888	CcSEcCtD
Mefloquine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000104	0.000887	CcSEcCtD
Mefloquine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000104	0.000887	CcSEcCtD
Mefloquine—Malaise—Prednisone—multiple sclerosis	0.000103	0.000883	CcSEcCtD
Mefloquine—Vertigo—Prednisone—multiple sclerosis	0.000103	0.000879	CcSEcCtD
Mefloquine—Eye disorder—Methotrexate—multiple sclerosis	0.000103	0.000878	CcSEcCtD
Mefloquine—Syncope—Prednisone—multiple sclerosis	0.000103	0.000878	CcSEcCtD
Mefloquine—Tinnitus—Methotrexate—multiple sclerosis	0.000103	0.000876	CcSEcCtD
Mefloquine—Urticaria—Prednisolone—multiple sclerosis	0.000102	0.000873	CcSEcCtD
Mefloquine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000102	0.000872	CcSEcCtD
Mefloquine—Fatigue—Triamcinolone—multiple sclerosis	0.000102	0.000872	CcSEcCtD
Mefloquine—Fatigue—Methylprednisolone—multiple sclerosis	0.000102	0.00087	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisone—multiple sclerosis	0.000101	0.00086	CcSEcCtD
Mefloquine—Hypotension—Betamethasone—multiple sclerosis	0.0001	0.000857	CcSEcCtD
Mefloquine—Hypotension—Dexamethasone—multiple sclerosis	0.0001	0.000857	CcSEcCtD
Mefloquine—Angiopathy—Methotrexate—multiple sclerosis	9.99e-05	0.000853	CcSEcCtD
Mefloquine—Vomiting—Mitoxantrone—multiple sclerosis	9.99e-05	0.000852	CcSEcCtD
Mefloquine—Convulsion—Prednisone—multiple sclerosis	9.94e-05	0.000848	CcSEcCtD
Mefloquine—Mediastinal disorder—Methotrexate—multiple sclerosis	9.93e-05	0.000847	CcSEcCtD
Mefloquine—Hypertension—Prednisone—multiple sclerosis	9.91e-05	0.000845	CcSEcCtD
Mefloquine—Rash—Mitoxantrone—multiple sclerosis	9.9e-05	0.000845	CcSEcCtD
Mefloquine—Dermatitis—Mitoxantrone—multiple sclerosis	9.89e-05	0.000844	CcSEcCtD
Mefloquine—Chills—Methotrexate—multiple sclerosis	9.88e-05	0.000843	CcSEcCtD
Mefloquine—Headache—Mitoxantrone—multiple sclerosis	9.84e-05	0.000839	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.8e-05	0.000836	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.8e-05	0.000836	CcSEcCtD
Mefloquine—Myalgia—Prednisone—multiple sclerosis	9.77e-05	0.000833	CcSEcCtD
Mefloquine—Arthralgia—Prednisone—multiple sclerosis	9.77e-05	0.000833	CcSEcCtD
Mefloquine—Feeling abnormal—Triamcinolone—multiple sclerosis	9.76e-05	0.000833	CcSEcCtD
Mefloquine—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.74e-05	0.000831	CcSEcCtD
Mefloquine—Anxiety—Prednisone—multiple sclerosis	9.73e-05	0.00083	CcSEcCtD
Mefloquine—Alopecia—Methotrexate—multiple sclerosis	9.73e-05	0.00083	CcSEcCtD
Mefloquine—Insomnia—Dexamethasone—multiple sclerosis	9.72e-05	0.00083	CcSEcCtD
Mefloquine—Insomnia—Betamethasone—multiple sclerosis	9.72e-05	0.00083	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.7e-05	0.000828	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.67e-05	0.000825	CcSEcCtD
Mefloquine—Paraesthesia—Betamethasone—multiple sclerosis	9.65e-05	0.000824	CcSEcCtD
Mefloquine—Paraesthesia—Dexamethasone—multiple sclerosis	9.65e-05	0.000824	CcSEcCtD
Mefloquine—Discomfort—Prednisone—multiple sclerosis	9.65e-05	0.000823	CcSEcCtD
Mefloquine—Mental disorder—Methotrexate—multiple sclerosis	9.65e-05	0.000823	CcSEcCtD
Mefloquine—Malnutrition—Methotrexate—multiple sclerosis	9.59e-05	0.000818	CcSEcCtD
Mefloquine—Erythema—Methotrexate—multiple sclerosis	9.59e-05	0.000818	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisolone—multiple sclerosis	9.49e-05	0.00081	CcSEcCtD
Mefloquine—Dyspepsia—Dexamethasone—multiple sclerosis	9.46e-05	0.000807	CcSEcCtD
Mefloquine—Dyspepsia—Betamethasone—multiple sclerosis	9.46e-05	0.000807	CcSEcCtD
Mefloquine—Urticaria—Triamcinolone—multiple sclerosis	9.41e-05	0.000803	CcSEcCtD
Mefloquine—Urticaria—Methylprednisolone—multiple sclerosis	9.39e-05	0.000801	CcSEcCtD
Mefloquine—Body temperature increased—Triamcinolone—multiple sclerosis	9.37e-05	0.000799	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisone—multiple sclerosis	9.36e-05	0.000799	CcSEcCtD
Mefloquine—Oedema—Prednisone—multiple sclerosis	9.36e-05	0.000799	CcSEcCtD
Mefloquine—Abdominal pain—Methylprednisolone—multiple sclerosis	9.35e-05	0.000797	CcSEcCtD
Mefloquine—Decreased appetite—Dexamethasone—multiple sclerosis	9.35e-05	0.000797	CcSEcCtD
Mefloquine—Decreased appetite—Betamethasone—multiple sclerosis	9.35e-05	0.000797	CcSEcCtD
Mefloquine—Nausea—Mitoxantrone—multiple sclerosis	9.33e-05	0.000796	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.28e-05	0.000792	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.28e-05	0.000792	CcSEcCtD
Mefloquine—Fatigue—Dexamethasone—multiple sclerosis	9.27e-05	0.000791	CcSEcCtD
Mefloquine—Fatigue—Betamethasone—multiple sclerosis	9.27e-05	0.000791	CcSEcCtD
Mefloquine—Shock—Prednisone—multiple sclerosis	9.21e-05	0.000786	CcSEcCtD
Mefloquine—Nervous system disorder—Prednisone—multiple sclerosis	9.18e-05	0.000783	CcSEcCtD
Mefloquine—Tachycardia—Prednisone—multiple sclerosis	9.14e-05	0.00078	CcSEcCtD
Mefloquine—Skin disorder—Prednisone—multiple sclerosis	9.09e-05	0.000776	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisone—multiple sclerosis	9.05e-05	0.000772	CcSEcCtD
Mefloquine—Vision blurred—Methotrexate—multiple sclerosis	9.04e-05	0.000771	CcSEcCtD
Mefloquine—Ill-defined disorder—Methotrexate—multiple sclerosis	8.9e-05	0.000759	CcSEcCtD
Mefloquine—Feeling abnormal—Betamethasone—multiple sclerosis	8.86e-05	0.000756	CcSEcCtD
Mefloquine—Feeling abnormal—Dexamethasone—multiple sclerosis	8.86e-05	0.000756	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.79e-05	0.00075	CcSEcCtD
Mefloquine—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.79e-05	0.00075	CcSEcCtD
Mefloquine—Hypersensitivity—Triamcinolone—multiple sclerosis	8.73e-05	0.000745	CcSEcCtD
Mefloquine—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.71e-05	0.000743	CcSEcCtD
Mefloquine—Malaise—Methotrexate—multiple sclerosis	8.65e-05	0.000738	CcSEcCtD
Mefloquine—Vertigo—Methotrexate—multiple sclerosis	8.61e-05	0.000735	CcSEcCtD
Mefloquine—Leukopenia—Methotrexate—multiple sclerosis	8.58e-05	0.000732	CcSEcCtD
Mefloquine—Urticaria—Dexamethasone—multiple sclerosis	8.54e-05	0.000729	CcSEcCtD
Mefloquine—Urticaria—Betamethasone—multiple sclerosis	8.54e-05	0.000729	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.53e-05	0.000728	CcSEcCtD
Mefloquine—Dizziness—Prednisolone—multiple sclerosis	8.52e-05	0.000727	CcSEcCtD
Mefloquine—Asthenia—Triamcinolone—multiple sclerosis	8.5e-05	0.000725	CcSEcCtD
Mefloquine—Abdominal pain—Betamethasone—multiple sclerosis	8.5e-05	0.000725	CcSEcCtD
Mefloquine—Body temperature increased—Betamethasone—multiple sclerosis	8.5e-05	0.000725	CcSEcCtD
Mefloquine—Body temperature increased—Dexamethasone—multiple sclerosis	8.5e-05	0.000725	CcSEcCtD
Mefloquine—Abdominal pain—Dexamethasone—multiple sclerosis	8.5e-05	0.000725	CcSEcCtD
Mefloquine—Asthenia—Methylprednisolone—multiple sclerosis	8.48e-05	0.000724	CcSEcCtD
Mefloquine—Insomnia—Prednisone—multiple sclerosis	8.47e-05	0.000723	CcSEcCtD
Mefloquine—Paraesthesia—Prednisone—multiple sclerosis	8.41e-05	0.000717	CcSEcCtD
Mefloquine—Pruritus—Triamcinolone—multiple sclerosis	8.38e-05	0.000715	CcSEcCtD
Mefloquine—Pruritus—Methylprednisolone—multiple sclerosis	8.36e-05	0.000714	CcSEcCtD
Mefloquine—Convulsion—Methotrexate—multiple sclerosis	8.31e-05	0.000709	CcSEcCtD
Mefloquine—Dyspepsia—Prednisone—multiple sclerosis	8.24e-05	0.000703	CcSEcCtD
Mefloquine—Myalgia—Methotrexate—multiple sclerosis	8.16e-05	0.000696	CcSEcCtD
Mefloquine—Chest pain—Methotrexate—multiple sclerosis	8.16e-05	0.000696	CcSEcCtD
Mefloquine—Arthralgia—Methotrexate—multiple sclerosis	8.16e-05	0.000696	CcSEcCtD
Mefloquine—Decreased appetite—Prednisone—multiple sclerosis	8.14e-05	0.000694	CcSEcCtD
Mefloquine—Rash—Prednisolone—multiple sclerosis	8.12e-05	0.000693	CcSEcCtD
Mefloquine—Dermatitis—Prednisolone—multiple sclerosis	8.12e-05	0.000692	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.11e-05	0.000692	CcSEcCtD
Mefloquine—Diarrhoea—Methylprednisolone—multiple sclerosis	8.09e-05	0.00069	CcSEcCtD
Mefloquine—Fatigue—Prednisone—multiple sclerosis	8.07e-05	0.000689	CcSEcCtD
Mefloquine—Headache—Prednisolone—multiple sclerosis	8.07e-05	0.000689	CcSEcCtD
Mefloquine—Discomfort—Methotrexate—multiple sclerosis	8.06e-05	0.000688	CcSEcCtD
Mefloquine—Confusional state—Methotrexate—multiple sclerosis	7.89e-05	0.000673	CcSEcCtD
Mefloquine—Dizziness—Triamcinolone—multiple sclerosis	7.84e-05	0.000669	CcSEcCtD
Mefloquine—Anaphylactic shock—Methotrexate—multiple sclerosis	7.83e-05	0.000668	CcSEcCtD
Mefloquine—Dizziness—Methylprednisolone—multiple sclerosis	7.82e-05	0.000667	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisone—multiple sclerosis	7.72e-05	0.000658	CcSEcCtD
Mefloquine—Asthenia—Betamethasone—multiple sclerosis	7.71e-05	0.000658	CcSEcCtD
Mefloquine—Asthenia—Dexamethasone—multiple sclerosis	7.71e-05	0.000658	CcSEcCtD
Mefloquine—Nervous system disorder—Methotrexate—multiple sclerosis	7.67e-05	0.000655	CcSEcCtD
Mefloquine—Thrombocytopenia—Methotrexate—multiple sclerosis	7.66e-05	0.000654	CcSEcCtD
Mefloquine—Gastrointestinal pain—Prednisone—multiple sclerosis	7.66e-05	0.000653	CcSEcCtD
Mefloquine—Nausea—Prednisolone—multiple sclerosis	7.65e-05	0.000653	CcSEcCtD
Mefloquine—Pruritus—Betamethasone—multiple sclerosis	7.61e-05	0.000649	CcSEcCtD
Mefloquine—Pruritus—Dexamethasone—multiple sclerosis	7.61e-05	0.000649	CcSEcCtD
Mefloquine—Skin disorder—Methotrexate—multiple sclerosis	7.6e-05	0.000648	CcSEcCtD
Mefloquine—Hyperhidrosis—Methotrexate—multiple sclerosis	7.56e-05	0.000645	CcSEcCtD
Mefloquine—Vomiting—Triamcinolone—multiple sclerosis	7.53e-05	0.000643	CcSEcCtD
Mefloquine—Vomiting—Methylprednisolone—multiple sclerosis	7.52e-05	0.000641	CcSEcCtD
Mefloquine—Rash—Triamcinolone—multiple sclerosis	7.47e-05	0.000637	CcSEcCtD
Mefloquine—Dermatitis—Triamcinolone—multiple sclerosis	7.46e-05	0.000637	CcSEcCtD
Mefloquine—Rash—Methylprednisolone—multiple sclerosis	7.45e-05	0.000636	CcSEcCtD
Mefloquine—Dermatitis—Methylprednisolone—multiple sclerosis	7.45e-05	0.000635	CcSEcCtD
Mefloquine—Urticaria—Prednisone—multiple sclerosis	7.44e-05	0.000635	CcSEcCtD
Mefloquine—Headache—Triamcinolone—multiple sclerosis	7.42e-05	0.000633	CcSEcCtD
Mefloquine—Headache—Methylprednisolone—multiple sclerosis	7.41e-05	0.000632	CcSEcCtD
Mefloquine—Abdominal pain—Prednisone—multiple sclerosis	7.4e-05	0.000631	CcSEcCtD
Mefloquine—Body temperature increased—Prednisone—multiple sclerosis	7.4e-05	0.000631	CcSEcCtD
Mefloquine—Diarrhoea—Betamethasone—multiple sclerosis	7.36e-05	0.000628	CcSEcCtD
Mefloquine—Diarrhoea—Dexamethasone—multiple sclerosis	7.36e-05	0.000628	CcSEcCtD
Mefloquine—Hypotension—Methotrexate—multiple sclerosis	7.31e-05	0.000624	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.13e-05	0.000608	CcSEcCtD
Mefloquine—Dizziness—Dexamethasone—multiple sclerosis	7.11e-05	0.000607	CcSEcCtD
Mefloquine—Dizziness—Betamethasone—multiple sclerosis	7.11e-05	0.000607	CcSEcCtD
Mefloquine—Insomnia—Methotrexate—multiple sclerosis	7.08e-05	0.000604	CcSEcCtD
Mefloquine—Nausea—Triamcinolone—multiple sclerosis	7.04e-05	0.0006	CcSEcCtD
Mefloquine—Paraesthesia—Methotrexate—multiple sclerosis	7.03e-05	0.000599	CcSEcCtD
Mefloquine—Nausea—Methylprednisolone—multiple sclerosis	7.02e-05	0.000599	CcSEcCtD
Mefloquine—Dyspnoea—Methotrexate—multiple sclerosis	6.98e-05	0.000595	CcSEcCtD
Mefloquine—Somnolence—Methotrexate—multiple sclerosis	6.96e-05	0.000594	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisone—multiple sclerosis	6.9e-05	0.000589	CcSEcCtD
Mefloquine—Dyspepsia—Methotrexate—multiple sclerosis	6.89e-05	0.000588	CcSEcCtD
Mefloquine—Vomiting—Dexamethasone—multiple sclerosis	6.84e-05	0.000583	CcSEcCtD
Mefloquine—Vomiting—Betamethasone—multiple sclerosis	6.84e-05	0.000583	CcSEcCtD
Mefloquine—Decreased appetite—Methotrexate—multiple sclerosis	6.8e-05	0.00058	CcSEcCtD
Mefloquine—Rash—Dexamethasone—multiple sclerosis	6.78e-05	0.000578	CcSEcCtD
Mefloquine—Rash—Betamethasone—multiple sclerosis	6.78e-05	0.000578	CcSEcCtD
Mefloquine—Dermatitis—Betamethasone—multiple sclerosis	6.77e-05	0.000578	CcSEcCtD
Mefloquine—Dermatitis—Dexamethasone—multiple sclerosis	6.77e-05	0.000578	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.76e-05	0.000576	CcSEcCtD
Mefloquine—Fatigue—Methotrexate—multiple sclerosis	6.75e-05	0.000576	CcSEcCtD
Mefloquine—Headache—Dexamethasone—multiple sclerosis	6.74e-05	0.000575	CcSEcCtD
Mefloquine—Headache—Betamethasone—multiple sclerosis	6.74e-05	0.000575	CcSEcCtD
Mefloquine—Asthenia—Prednisone—multiple sclerosis	6.72e-05	0.000573	CcSEcCtD
Mefloquine—Pruritus—Prednisone—multiple sclerosis	6.62e-05	0.000565	CcSEcCtD
Mefloquine—Feeling abnormal—Methotrexate—multiple sclerosis	6.45e-05	0.00055	CcSEcCtD
Mefloquine—Diarrhoea—Prednisone—multiple sclerosis	6.41e-05	0.000547	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.4e-05	0.000546	CcSEcCtD
Mefloquine—Nausea—Betamethasone—multiple sclerosis	6.39e-05	0.000545	CcSEcCtD
Mefloquine—Nausea—Dexamethasone—multiple sclerosis	6.39e-05	0.000545	CcSEcCtD
Mefloquine—Urticaria—Methotrexate—multiple sclerosis	6.22e-05	0.00053	CcSEcCtD
Mefloquine—Dizziness—Prednisone—multiple sclerosis	6.19e-05	0.000528	CcSEcCtD
Mefloquine—Abdominal pain—Methotrexate—multiple sclerosis	6.19e-05	0.000528	CcSEcCtD
Mefloquine—Body temperature increased—Methotrexate—multiple sclerosis	6.19e-05	0.000528	CcSEcCtD
Mefloquine—Vomiting—Prednisone—multiple sclerosis	5.95e-05	0.000508	CcSEcCtD
Mefloquine—Rash—Prednisone—multiple sclerosis	5.9e-05	0.000504	CcSEcCtD
Mefloquine—Dermatitis—Prednisone—multiple sclerosis	5.9e-05	0.000503	CcSEcCtD
Mefloquine—Headache—Prednisone—multiple sclerosis	5.87e-05	0.0005	CcSEcCtD
Mefloquine—Hypersensitivity—Methotrexate—multiple sclerosis	5.77e-05	0.000492	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—SRM—multiple sclerosis	5.72e-05	0.000839	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—APOE—multiple sclerosis	5.71e-05	0.000839	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LINGO1—multiple sclerosis	5.69e-05	0.000836	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.66e-05	0.000832	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCR5—multiple sclerosis	5.64e-05	0.000828	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL10—multiple sclerosis	5.62e-05	0.000825	CbGpPWpGaD
Mefloquine—Asthenia—Methotrexate—multiple sclerosis	5.61e-05	0.000479	CcSEcCtD
Mefloquine—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	5.61e-05	0.000823	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—S1PR1—multiple sclerosis	5.59e-05	0.00082	CbGpPWpGaD
Mefloquine—Nausea—Prednisone—multiple sclerosis	5.56e-05	0.000474	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—multiple sclerosis	5.55e-05	0.000815	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SRM—multiple sclerosis	5.55e-05	0.000815	CbGpPWpGaD
Mefloquine—Pruritus—Methotrexate—multiple sclerosis	5.54e-05	0.000472	CcSEcCtD
Mefloquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.49e-05	0.000806	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GPC5—multiple sclerosis	5.43e-05	0.000798	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL13—multiple sclerosis	5.38e-05	0.00079	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR1—multiple sclerosis	5.38e-05	0.00079	CbGpPWpGaD
Mefloquine—Diarrhoea—Methotrexate—multiple sclerosis	5.35e-05	0.000457	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.33e-05	0.000782	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—POMC—multiple sclerosis	5.3e-05	0.000778	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PTGER4—multiple sclerosis	5.27e-05	0.000773	CbGpPWpGaD
Mefloquine—Dizziness—Methotrexate—multiple sclerosis	5.17e-05	0.000441	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—CXCR3—multiple sclerosis	5.09e-05	0.000747	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CD80—multiple sclerosis	5.06e-05	0.000743	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	5.06e-05	0.000742	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	5e-05	0.000734	CbGpPWpGaD
Mefloquine—Vomiting—Methotrexate—multiple sclerosis	4.98e-05	0.000424	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL3—multiple sclerosis	4.97e-05	0.000729	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR2—multiple sclerosis	4.95e-05	0.000726	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TAGAP—multiple sclerosis	4.93e-05	0.000725	CbGpPWpGaD
Mefloquine—Rash—Methotrexate—multiple sclerosis	4.93e-05	0.000421	CcSEcCtD
Mefloquine—Dermatitis—Methotrexate—multiple sclerosis	4.93e-05	0.000421	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.92e-05	0.000723	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—POMC—multiple sclerosis	4.91e-05	0.00072	CbGpPWpGaD
Mefloquine—Headache—Methotrexate—multiple sclerosis	4.9e-05	0.000418	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CCL5—multiple sclerosis	4.83e-05	0.00071	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PTGER4—multiple sclerosis	4.78e-05	0.000702	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RGS1—multiple sclerosis	4.75e-05	0.000697	CbGpPWpGaD
Mefloquine—Nausea—Methotrexate—multiple sclerosis	4.65e-05	0.000397	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CXCR3—multiple sclerosis	4.62e-05	0.000678	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CNR1—multiple sclerosis	4.57e-05	0.00067	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	4.51e-05	0.000662	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GPR65—multiple sclerosis	4.5e-05	0.000661	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR2—multiple sclerosis	4.49e-05	0.00066	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—multiple sclerosis	4.47e-05	0.000657	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.47e-05	0.000656	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.45e-05	0.000654	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—POMC—multiple sclerosis	4.41e-05	0.000647	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP27B1—multiple sclerosis	4.38e-05	0.000643	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP24A1—multiple sclerosis	4.38e-05	0.000643	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.38e-05	0.000643	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.37e-05	0.000642	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCR5—multiple sclerosis	4.36e-05	0.00064	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL2—multiple sclerosis	4.31e-05	0.000633	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—S1PR1—multiple sclerosis	4.31e-05	0.000633	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.28e-05	0.000629	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—TYK2—multiple sclerosis	4.27e-05	0.000627	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.26e-05	0.000625	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GPC5—multiple sclerosis	4.2e-05	0.000616	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CNR1—multiple sclerosis	4.15e-05	0.000609	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL13—multiple sclerosis	4.12e-05	0.000605	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR1—multiple sclerosis	4.12e-05	0.000605	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL10—multiple sclerosis	4.11e-05	0.000604	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	4.07e-05	0.000597	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	4.03e-05	0.000591	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	4.03e-05	0.000591	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GPC5—multiple sclerosis	4.01e-05	0.000589	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.96e-05	0.000582	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.94e-05	0.000578	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	3.93e-05	0.000577	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP24A1—multiple sclerosis	3.91e-05	0.000574	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP27B1—multiple sclerosis	3.91e-05	0.000574	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.89e-05	0.000571	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	3.89e-05	0.000571	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL3—multiple sclerosis	3.84e-05	0.000563	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR2—multiple sclerosis	3.82e-05	0.000561	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL10—multiple sclerosis	3.73e-05	0.000548	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	3.7e-05	0.000543	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTGER4—multiple sclerosis	3.69e-05	0.000542	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GPC5—multiple sclerosis	3.68e-05	0.000541	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RGS1—multiple sclerosis	3.67e-05	0.000539	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.59e-05	0.000527	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—multiple sclerosis	3.59e-05	0.000527	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GPC5—multiple sclerosis	3.58e-05	0.000525	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCR3—multiple sclerosis	3.57e-05	0.000524	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCL5—multiple sclerosis	3.54e-05	0.00052	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	3.53e-05	0.000519	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CNR1—multiple sclerosis	3.52e-05	0.000518	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GPR65—multiple sclerosis	3.48e-05	0.000511	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.47e-05	0.000509	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR2—multiple sclerosis	3.47e-05	0.000509	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.46e-05	0.000508	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.42e-05	0.000502	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—POMC—multiple sclerosis	3.4e-05	0.0005	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	3.4e-05	0.000499	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL2—multiple sclerosis	3.33e-05	0.000489	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	3.32e-05	0.000488	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—RRM1—multiple sclerosis	3.32e-05	0.000488	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.32e-05	0.000487	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCL5—multiple sclerosis	3.21e-05	0.000472	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CNR1—multiple sclerosis	3.2e-05	0.00047	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR5—multiple sclerosis	3.19e-05	0.000468	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR1—multiple sclerosis	3.18e-05	0.000467	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL13—multiple sclerosis	3.18e-05	0.000467	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	3.17e-05	0.000466	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.14e-05	0.000461	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.06e-05	0.00045	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.06e-05	0.000449	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—RRM1—multiple sclerosis	3.05e-05	0.000448	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3e-05	0.00044	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—STAT3—multiple sclerosis	2.99e-05	0.000439	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—RRM1—multiple sclerosis	2.96e-05	0.000435	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL3—multiple sclerosis	2.93e-05	0.000431	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.93e-05	0.00043	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.91e-05	0.000427	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR5—multiple sclerosis	2.89e-05	0.000425	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.89e-05	0.000424	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL10—multiple sclerosis	2.88e-05	0.000423	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.85e-05	0.000419	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2RA—multiple sclerosis	2.85e-05	0.000419	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTGER4—multiple sclerosis	2.82e-05	0.000415	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PGR—multiple sclerosis	2.78e-05	0.000408	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—multiple sclerosis	2.77e-05	0.000407	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCL5—multiple sclerosis	2.73e-05	0.000401	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCR3—multiple sclerosis	2.73e-05	0.000401	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—MAPK1—multiple sclerosis	2.72e-05	0.000399	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	2.71e-05	0.000399	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SRM—multiple sclerosis	2.71e-05	0.000398	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD28—multiple sclerosis	2.7e-05	0.000397	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.7e-05	0.000396	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR2—multiple sclerosis	2.65e-05	0.00039	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.62e-05	0.000385	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.58e-05	0.000378	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.58e-05	0.000378	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.55e-05	0.000375	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.52e-05	0.00037	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—POMC—multiple sclerosis	2.49e-05	0.000366	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL5—multiple sclerosis	2.48e-05	0.000364	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR5—multiple sclerosis	2.46e-05	0.000361	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CNR1—multiple sclerosis	2.45e-05	0.00036	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.43e-05	0.000356	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.37e-05	0.000348	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.36e-05	0.000347	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.32e-05	0.000341	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.3e-05	0.000338	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL3—multiple sclerosis	2.27e-05	0.000333	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—POMC—multiple sclerosis	2.26e-05	0.000332	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.24e-05	0.000328	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCL2—multiple sclerosis	2.21e-05	0.000325	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—MAPK1—multiple sclerosis	2.21e-05	0.000325	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.21e-05	0.000325	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL10—multiple sclerosis	2.21e-05	0.000324	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.2e-05	0.000323	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTGER4—multiple sclerosis	2.18e-05	0.00032	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PGR—multiple sclerosis	2.15e-05	0.000315	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCR3—multiple sclerosis	2.11e-05	0.000309	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—multiple sclerosis	2.09e-05	0.000307	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD28—multiple sclerosis	2.09e-05	0.000306	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR2—multiple sclerosis	2.05e-05	0.000301	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.03e-05	0.000299	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.02e-05	0.000296	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TYK2—multiple sclerosis	2.01e-05	0.000295	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—MAPK1—multiple sclerosis	1.97e-05	0.00029	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.97e-05	0.00029	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD86—multiple sclerosis	1.93e-05	0.000283	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.92e-05	0.000282	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—POMC—multiple sclerosis	1.91e-05	0.000281	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—BCHE—multiple sclerosis	1.91e-05	0.00028	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.91e-05	0.00028	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.91e-05	0.00028	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL5—multiple sclerosis	1.9e-05	0.000279	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CNR1—multiple sclerosis	1.89e-05	0.000278	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	1.87e-05	0.000275	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.85e-05	0.000272	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—multiple sclerosis	1.84e-05	0.00027	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.8e-05	0.000264	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.8e-05	0.000264	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.8e-05	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—multiple sclerosis	1.76e-05	0.000258	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000257	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—POMC—multiple sclerosis	1.75e-05	0.000257	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.000256	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—multiple sclerosis	1.71e-05	0.000251	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.71e-05	0.000251	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—POMC—multiple sclerosis	1.71e-05	0.000251	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.7e-05	0.00025	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2RA—multiple sclerosis	1.69e-05	0.000247	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	0.000246	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	1.67e-05	0.000245	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.67e-05	0.000245	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.64e-05	0.000241	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—multiple sclerosis	1.56e-05	0.000228	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.55e-05	0.000228	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.55e-05	0.000227	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD86—multiple sclerosis	1.49e-05	0.000219	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL5—multiple sclerosis	1.47e-05	0.000215	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.45e-05	0.000212	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.42e-05	0.000209	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD80—multiple sclerosis	1.41e-05	0.000207	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.36e-05	0.0002	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—multiple sclerosis	1.36e-05	0.000199	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—POMC—multiple sclerosis	1.34e-05	0.000196	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.33e-05	0.000196	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.33e-05	0.000195	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—multiple sclerosis	1.32e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL2—multiple sclerosis	1.31e-05	0.000192	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.3e-05	0.000192	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.3e-05	0.000191	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—multiple sclerosis	1.29e-05	0.00019	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—MAPK1—multiple sclerosis	1.28e-05	0.000188	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.24e-05	0.000182	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—multiple sclerosis	1.2e-05	0.000176	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TYK2—multiple sclerosis	1.19e-05	0.000174	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.18e-05	0.000173	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.18e-05	0.000173	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000168	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD80—multiple sclerosis	1.09e-05	0.000159	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.07e-05	0.000158	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—POMC—multiple sclerosis	1.03e-05	0.000152	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—multiple sclerosis	1.02e-05	0.00015	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—multiple sclerosis	1.01e-05	0.000148	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—multiple sclerosis	9.88e-06	0.000145	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.88e-06	0.000145	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—POMC—multiple sclerosis	9.86e-06	0.000145	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—multiple sclerosis	9.83e-06	0.000144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—multiple sclerosis	9.35e-06	0.000137	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TYK2—multiple sclerosis	9.17e-06	0.000135	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—POMC—multiple sclerosis	9.06e-06	0.000133	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—multiple sclerosis	8.99e-06	0.000132	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.91e-06	0.000131	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—POMC—multiple sclerosis	8.79e-06	0.000129	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.35e-06	0.000123	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—multiple sclerosis	8.31e-06	0.000122	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BCHE—multiple sclerosis	8.3e-06	0.000122	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—multiple sclerosis	8.26e-06	0.000121	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—multiple sclerosis	8.02e-06	0.000118	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.82e-06	0.000115	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—multiple sclerosis	7.73e-06	0.000113	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—multiple sclerosis	7.71e-06	0.000113	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—multiple sclerosis	7.63e-06	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—multiple sclerosis	7.59e-06	0.000111	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK1—multiple sclerosis	7.56e-06	0.000111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—multiple sclerosis	7.22e-06	0.000106	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—multiple sclerosis	6.42e-06	9.43e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—multiple sclerosis	5.97e-06	8.76e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.95e-06	8.74e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.84e-06	8.57e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—multiple sclerosis	5.81e-06	8.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.12e-06	7.51e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—multiple sclerosis	4.99e-06	7.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.71e-06	6.91e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—multiple sclerosis	4.48e-06	6.58e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—POMC—multiple sclerosis	4.29e-06	6.3e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.04e-06	5.94e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—multiple sclerosis	3.91e-06	5.74e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.69e-06	5.41e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.08e-06	4.52e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.64e-06	3.88e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.41e-06	3.54e-05	CbGpPWpGaD
